Author

D. Blaas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Adonyi· 1 shared A.-D. Gorki· 1 shared D. Stoeva· 1 shared G. A. Gualdoni· 1 shared I. Goesler· 1 shared J. Stoeckl· 1 shared L. Wali· 1 shared M. Karbiener· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Adonyi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2

L. Wali, M. Karbiener, S. Chou, V. Kovtunyk, A. Adonyi, I. Goesler, X. Contreras, D. Stoeva, D. Blaas, J. Stoeckl, T. R. Kreil, G. A. Gualdoni, A.-D. Gorki

This study shows 2-deoxy-D-glucose inhibits replication of rhinoviruses, endemic coronaviruses, and SARS-CoV-2 in epithelial cells by disrupting viral RNA synthesis and reducing viral load.

bioRxiv · May 24, 2022Microbiology